Related by context. All words. (Click for frequent words.) 71 Omigard TM 70 IV APAP 69 Crofelemer budesonide foam 69 Silenor ® doxepin 69 Generx TM 69 KRYSTEXXA TM 68 Empatic ™ 68 sNDAs 68 SinuNase ™ 68 highly purified pasteurized 67 Oracea TM 67 signal detection CTSD 67 Amigal TM 67 5 lipoxygenase inhibitor 67 Omigard 67 DIFICID ™ 67 mesylate tablets approved 67 TRANSDUR ™ 67 Empatic TM 67 Submits Biologics License Application 67 FUSILEV ® 67 SinuNase TM 67 ELADUR ™ 66 Submits NDA 66 oncolytic virus therapies 66 Xcytrin R 66 R sorafenib tablets 66 Panzem R 66 TRANSDUR ® 66 Acetavance 66 KRYSTEXXA TM pegloticase 66 Cardium Therapeutics TM 66 budesonide MMX Phase III 66 Nycomed GmbH 66 commercialize CorMedix drug 66 JOULFERON 66 Second Pivotal Phase 66 IMPDH inhibitor 66 VIVITROL ® 66 TELINTRA R 65 Hematide ™ 65 Zenvia ™ 65 tivozanib AV 65 granted Ortec 65 Anturol ® 65 PNP inhibitor 65 MSCRAMM ® 65 pharmacogenomic translational research 65 candidate REP# 65 POSIDUR TM ELADUR TM 65 please visit http:/www.vandapharma.com 65 candidate deforolimus 65 successfully commercialize Iluvien 65 Aganocide 65 Files Investigational 65 Staphylococcus aureus Immune Globulin 65 Submits Supplemental 65 intravenous acetaminophen 65 BLA filing 65 Ketotransdel 65 XL# anticancer compounds 65 Somatuline R Autogel R 65 include Phenoptin TM 65 Testosterone MDTS ® 65 SYCREST 65 BUPHENYL R 65 Qutenza TM 65 StaphVAX R 65 Pruvel ™ prulifloxacin 65 dextromethorphan quinidine 64 forodesine hydrochloride 64 Nabi HB Intravenous 64 personalized cellular immunotherapy 64 pentadentate logo R 64 platforms GVAX 64 zolpidem tartrate sublingual tablet 64 PROVENGE ® 64 GATTEX TM 64 GVAX ® 64 markets HP Acthar 64 novel orally inhaled 64 BEMA ® 64 FACTIVE R gemifloxacin 64 delivers fluocinolone acetonide FA 64 PANVAC VF 64 molecular imaging radiopharmaceutical 64 MOVIPREP R 64 Initiates Enrollment 64 Q#IR 64 Peyronie disease Frozen Shoulder 64 Completes Patient Enrollment 64 OvaRex R 64 proprietary intravenous formulation 64 Surfaxin LS 64 NUEDEXTA ™ 64 Initiates Phase III 64 Announces Tentative Approval 64 ENABLE Phase 2 64 pralatrexate injection folate analogue 64 Oral Calcitonin 64 IV acetaminophen 64 formerly LymphoStat B 64 methylnaltrexone bromide 64 Excellarate TM 64 Cellegesic 64 Besivance 64 refractory chronic lymphocytic 64 PORxin TM platforms 64 Vitrasert R 64 ZEVALIN ® 64 Zemiva TM 64 please visit www.medicinova.com 64 SPRYCEL ® 64 overactive bladder AA# 64 Mylan Receives Approval 64 acyclovir Lauriad R 64 severe hypercholesterolemia 64 TRIOLEX HE# APOPTONE HE# 64 LibiGel ® 64 Aryplase 64 LEVADEX TM 64 HYVISC ® treatment 64 Prodarsan R 64 Thelin TM 64 Hematide ™ peginesatide 63 Budesonide foam crofelemer 63 JZP 63 topical non steroidal 63 candidate SILENOR TM 63 ZALBIN 63 Silenor ® 63 PDX pralatrexate 63 novel MetAP 2 63 commercialized DURECT 63 Gentamicin Surgical Implant 63 BioSante licensees 63 Biologic License Application BLA 63 NDA Submission 63 GATTEX ® 63 diagnostic radiopharmaceutical 63 Personalized Immunotherapy 63 investigational pharmacologically unique 63 Veronate R 63 EVIZON TM squalamine lactate 63 Levoleucovorin 63 cosmetic cosmeceutical products 63 balsalazide tablet 63 liver resection surgeries 63 Submits Response 63 Ganite ® 63 Pegloticase 63 Biomerix Corporation 63 Telik logo TELINTRA 63 nasal calcitonin product 63 Receives Approvable Letter 63 TRANSDUR Bupivacaine 63 Nasdaq NPSP announced 63 HuMax TAC 63 Asentar TM 63 selective A2A adenosine receptor 63 website www.celsion.com 63 ® bortezomib 63 Anturol TM 63 oxybutynin ATD TM 63 Nasdaq PGNX today 63 PF # [002] 63 CIP TRAMADOL ER 63 including eniluracil ADH 63 XP# XP# 63 Orapred ODT 63 candidate AQ4N 63 HEPLISAV ™ 63 Entereg alvimopan 63 Alseres Cethrin 63 Soliris TM eculizumab 63 PROMACTA ® 62 subsidiaries visit http:/www.apricusbio.com 62 recombinant PSMA vaccine 62 CD# CEA 62 LymphoStat B TM 62 Solzira TM 62 MAGE A3 ASCI 62 non porcine pancreatic 62 INTEGRILIN R eptifibatide Injection 62 Nicotine Conjugate Vaccine 62 CRMD# 62 ZEGERID Capsules 62 candidate XP# 62 MKC# MT 62 Initiate Clinical Trial 62 R rilonacept Injection 62 Kosan dependence 62 zileuton IV 62 OFIRMEV 62 Unigene nasal calcitonin 62 HP Acthar R 62 Exalgo TM 62 QNEXA ® 62 OFIRMEV TM 62 Pruvel 62 vapreotide acetate 62 SILENOR TM 62 memantine HCl 62 ALTROPANE R 62 SUMAVEL 62 ELADUR TM 62 Nasdaq VNDA 62 Receives Orphan Drug 62 forodesine 62 Exelbine 62 FDA Accepts 62 Evoltra ® 62 SPL# Gel vaginal microbicide 62 Intermezzo ® zolpidem tartrate 62 granulated mesalamine 62 OMAPRO ™ 62 please visit http:/www.atherogenics.com 62 BioGlue ® 62 Aganocide ® 62 ZEGERID Chewable Tablets 62 Orphan Drug designations 62 developing ostarine selective 62 AAG geldanamycin analog 62 IMiDs ® compound 62 P#X# antagonist 62 OvaRex ® MAb 62 developing ACAPODENE 62 BRILINTA 62 therefore therapeutically equivalent 62 Cleviprex TM clevidipine 62 inflammatory autoimmune diseases 62 Phase III Pivotal 62 Ofirmev 62 candidate epratuzumab 62 KNS # 62 zileuton CR 62 Files IND 62 Rhucin ® 62 Cardio Vascu Grow 62 Taro Receives 62 CoTherix logo 62 sterile lidocaine patch 62 modified glutathione analog 62 ASONEP TM 62 SILENOR 62 Through Glycoscience R 62 Initiates Phase II 62 transmucosal delivery system 62 hypoxia activated prodrug 62 COLAZAL R 62 investigational hepatitis B 62 Allovectin 7 62 Ceplene TM 62 CLIRS trial 62 topically applied SEPA 62 TOCOSOL Paclitaxel 62 Xyzal R 62 Gamunex C 62 proprietary Capillary Aerosolization Technology 62 investigational antiplatelet agent 62 ALVESCO R 62 PREOS R 62 orBec ® oral beclomethasone 61 Bayer HealthCare Onyx Pharmaceuticals 61 Unit Dose Budesonide 61 histamine dihydrochloride 61 evaluating satraplatin 61 treat chronic sinusitis 61 GLP1 INT TM 61 tiapamil 61 SUPPRELIN R LA 61 PLK1 SNALP 61 Immunotherapeutic 61 BioGlue R 61 VISICOL R 61 product candidate Lpathomab 61 delta opioid receptor 61 recombinant biopharmaceutical 61 Targretin capsules 61 Inc. www.micromet inc.com 61 FOLOTYN ® 61 Glufosfamide 61 ALN PCS 61 Cutanea Life Sciences 61 PDUFA Date 61 Fast Track Status 61 Eligard R 61 Receives Fast Track 61 Aloprim TM allopurinol sodium 61 Thalomid R 61 individualized cellular immunotherapy 61 TRANSDUR Sufentanil 61 novel L DOS# 61 Simulect 61 OTC ZEGERID 61 Panzem R NCD 61 Dyloject TM 61 treat opioid induced 61 Shigatoxin producing E. coli 61 Prednisporin 61 Romiplostim 61 XOMA 3AB 61 RhuDex ® 61 Dementia Related Psychosis 61 Vertex hepatitis C 61 Phase 2a clinical trials 61 JAK2 Inhibitor 61 technology visit http:/www.genmab.com 61 Urocortin 2 61 MAb therapy 61 oral methylnaltrexone 61 Solzira ™ 61 ITAX 61 thrombin component 61 BEMA Granisetron 61 Application BLA 61 trastuzumab DM1 T DM1 61 novel synthetic PEGylated 61 MSCRAMM R 61 Peginterferon alfa 2b 61 SPARLON 61 STRIANT ® 61 Combunox 61 PrevOnco ™ 61 testosterone gel LibiGel 61 Dyax logo 61 GLASSIA 61 RANK Ligand inhibitor 61 ® decitabine 61 Ramelteon 61 ibuprofen Injection 61 Zelrix 61 initiate multicenter 61 successfully commercialize Silenor 61 dihydrochloride Phase 3 61 ACEON R perindopril erbumine 61 authority Gurian Sherman 61 ionotropic glutamate receptor antagonists 61 BENLYSTA TM 61 Dexilant 61 novel therapeutic antibodies 61 Polyphenon ® E 61 palonosetron hydrochloride Injection Dacogen 61 Sumatriptan Succinate 61 visit www.sciclone.com 61 MAA submission 61 inhaled liposomal ciprofloxacin 61 novel emulsion formulation 61 Vitamin D analogue 61 TKB# 61 Pivotal Phase III 61 leading oral taxane 61 visit www.targanta.com 61 T Pred 61 Eloxatin ® 61 BiDil XR 61 Emezine 61 HEPLISAV TM 61 motexafin gadolinium Injection 61 designated Restanza 61 Fortical R 61 Liprotamase 61 include Healive 61 Tarceva TM 61 Zolpimist 61 NeuroSTAT ® 61 compound KOS 61 Zolpimist ™ 61 AcryMed Incorporated 61 Restoraderm R 61 Inc. AMEX YMI 61 Oral NKTR 61 Entereg R 61 AzaSite Plus 61 human C1 inhibitor 61 biomimetics non 61 Nipent R 61 Xyrem ® 61 Fast Track designations 61 oral prodrug 61 Amoxicillin PULSYS 61 Aphthasol R 61 valtorcitabine 61 Linjeta TM 61 Initiate Phase 61 oral picoplatin 61 ENRICH trial 61 HepeX B 61 Locteron ® 61 anti botulism antibody 61 lintuzumab SGN 61 anti CD3 monoclonal 61 Nanobody R 61 Biologics License Application 61 Zemiva TM Trofex TM 61 Granted Orphan Drug 61 sodium thiosulfate STS 60 AcryMed technologies 60 AVINZA ® 60 Risperidone Oral Solution 60 TELINTRA 60 BioDelivery Sciences 60 Entereg TM 60 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 60 Surgical Adhesive 60 Ecallantide 60 Iluvien TM 60 please visit www.advaxis.com 60 eprodisate Fibrillex TM 60 EGRIFTA TM 60 CIMZIA r 60 REMOXY R 60 AMITIZA ® 60 DPX Survivac 60 R DepoCyt 60 casopitant 60 diagnostic molecular imaging 60 vinorelbine tartrate 60 Arzerra TM 60 supplemental Biologics License Application 60 oral calcitonin 60 sorafenib tablets 60 TRIOLEX ™ 60 initiated Phase Ib 60 Topline Results 60 website www.nyandcompany.com 60 midstage clinical 60 telomerase therapeutic 60 PrevOnco 60 Protexia ® 60 Ketotransdel ® 60 Initiated Phase 60 Kuvan R 60 vaccines oncolytic virus 60 Puricase PEG uricase 60 website http:/www.celsion.com 60 Meets Primary Endpoint 60 OMNARIS HFA 60 Pulsys 60 XIAFLEX ™ 60 dihydrochloride Tablets 60 Iluvien ® 60 Raptiva R 60 targeted radiotherapeutic 60 Solazed TM 60 Receives Orphan Drug Designation 60 carcinoid syndrome 60 aldehyde dehydrogenase ALDH2 deficiency 60 Augment TM 60 PDE4 inhibitor 60 Zingo TM 60 R#/MEM # 60 Zorbtive TM 60 Panflu TM 60 Proellex TM 60 Troxatyl 60 DAYTRANA TM 60 pancreatic enzyme replacement 60 proprietary transdermal patch 60 Fodosine 60 Phenoptin 60 LEVADEX ™ 60 kidney urologic 60 OAB overactive bladder 60 Aztreonam lysine 60 Ostabolin C TM 60 Silodosin 60 VEGFR2 inhibitor 60 Luveris R Ovidrel R 60 Plicera 60 URG# 60 GTC recombinant form 60 treats acute lymphoblastic 60 Marketing Approval PMA 60 XAGRID 60 Febuxostat 60 Prochymal TM 60 Duromist ™ 60 faropenem medoxomil 60 By JENNIFER LEARN 60 Rexahn licensees 60 confirmatory pivotal 60 rasagiline tablets 60 Belimumab 60 HCV RNA polymerase 60 BLP# Liposome Vaccine 60 Trobalt 60 evaluating picoplatin 60 Begins Dosing 60 non nucleoside HCV 60 novel proprietary KL4 60 miconazole Lauriad ® 60 FavId 60 Meleanie Hain loaded 60 submitted Biologics License 60 approved incretin mimetic 60 Shigamabs ® 60 candidate Zemiva TM 60 torsemide ER 60 HEPLISAV TM hepatitis B 60 Janis Joplin soundalike respiratory 60 Focalin XR ® 60 allosteric modulator PAM 60 VANTAS ® 60 Rosetta dependence 60 product platforms GVAX 60 NicVAX TM 60 fusion enhancers 60 Delta opioid receptor 60 use transdermal sumatriptan 60 confirmatory Phase III 60 NASDAQ BDSI 60 corticotropin injection 60 Ondansetron Injection 60 nalbuphine ER 60 Marketing Authorisation Application 60 Phase IIb clinical trials 60 Allovectin 7 r 60 Menerba 60 solid tumors ZYBRESTAT 60 acetonide FA 60 GATTEX ™ 60 Preotact R 60 cicletanine 60 Inc. Nasdaq VVUS 60 candidates Azedra TM 60 OLEPTRO 60 label Lipofen R 60 Zemiva ™ 60 rheumatoid arthritis thrombocytopenia 60 Archexin 60 Marketing Authorization Application 60 Akorn Strides 60 IMiDs R 60 Increlex TM 60 Lamictal ODT 60 TYZEKA 60 R lenalidomide 60 www.adeonapharma.com 60 faropenem 60 ViaCord R 60 catheter occlusion 60 androgen receptor modulator 60 LUCASSIN 60 Loramyc TM 60 vosaroxin 60 Veronate 60 NASDAQ DYAX 60 REG1 Anticoagulation System 60 commercialize ZYFLO CR 60 Nascobal ® 60 BiovaxID TM 60 Vion Pharmaceuticals 60 sitaxsentan 60 RAPTIVA r 60 Frova ® 60 Canvaxin TM 60 Zanaflex Capsules ® tizanidine 60 novel histone deacetylase 60 Albugon 60 MCSP respectively 60 clinical trials dacetuzumab SGN 60 include PLX IBD 60 GTC recombinant human 60 Pivotal Phase 60 Argatroban 60 Marketing Authorisation Application MAA 60 BioSante Pharmaceuticals Announces 60 Elagolix 60 MUSE ® 59 Aloxi Injection 59 Clolar ® 59 Tibotec Therapeutics division 59 dasatinib Sprycel ® 59 Somatuline Depot 59 www.cellgenesys.com 59 albiglutide 59 Phase III Clinical Trial 59 INSPIRE Trial Phase III 59 Kyowa Kirin 59 Prochieve R 59 PRECISE Trial 59 Trastuzumab DM1 59 sumatriptan injection 59 CB2 selective receptor agonist 59 OTCBB HXBM developer 59 http:/www.celgene.com 59 Successfully Completes Phase 59 Zavesca r 59 REMOXY POSIDUR ELADUR 59 GVAX R 59 Vidaza R 59 rALLy clinical trial 59 ABRAXANE TM 59 STELARA TM 59 mGluR2 positive 59 KRYSTEXXA 59 Captisol enabled 59 novel VDA molecule 59 Other ImmunoGen collaborative 59 POSIDUR ™ 59 Gel repository corticotropin injection 59 Initiates Clinical 59 ZANAFLEX CAPSULES ® tizanidine 59 topical gel formulation 59 include Altastaph TM 59 Orphan Status 59 Ezogabine 59 Alzhemed TM 59 5 HT2A inverse 59 fluorinated carbohydrate mimics 59 Phase IIb Trial 59 intranasal formulation 59 Application MAA 59 delivery polymer matrix 59 STRIANT R 59 ThermoDox ® clinical 59 Androxal TM 59 include Alferon N 59 Staphylococcus aureus Polysaccharide Conjugate 59 Rotarix ® 59 XL# XL# XL# XL# 59 IV Busulfex 59 epoetin zeta 59 SUCCEED trial 59 visit smith.com 59 CYT# potent vascular disrupting 59 Rescula 59 IND Filing 59 NASDAQ OSIR 59 Xibrom TM 59 agonistic human 59 Ceflatonin R 59 treat dysmenorrhea 59 generation purine nucleoside 59 Georges Gemayel 59 treat lupus renal 59 compound CIP FENOFIBRATE 59 Contrave NDA 59 evaluating bafetinib 59 Alnylam dependence 59 Drug Eluting Stent System 59 NasdaqGM NTEC today 59 phase III isavuconazole 59 HCD# [002] 59 RAPTIVA 59 recurrent metastatic ovarian cancer 59 ACAPODENE TM 59 Sanctura XR 59 BioDelivery Sciences Announces 59 RECOTHROM R 59 octreotide implant 59 drug pipeline TAFA# 59 RECOTHROM ® 59 supplemental biologics 59 Xolegel 59 intravesical infusion therapy 59 Sodium oxybate 59 vinorelbine emulsion 59 Urocidin TM 59 Phase 2b Clinical Trial 59 HuMax CD#b 59 Tesetaxel 59 Femring ® 59 Patient Enrollment 59 ELADUR 59 assigned PDUFA 59 ALN HPN 59 IONSYS TM 59 herpetic keratitis 59 Genitope Corporation 59 Fx #A 59 Biologics License Application BLA 59 Ixempra 59 Specifid 59 Earns Milestone Payment 59 fluvoxamine maleate 59 Captisol ® 59 Demonstrates Sustained 59 Benazepril 59 oxypurinol 59 designated cethromycin 59 candidate Serada 59 TFChem licenses 59 NEBIDO R 59 candidates Augment ™ 59 Skin Cholesterol Test 59 ENZON 59 Surfaxin lucinactant 59 interferon gamma 1b 59 autologous cellular immunotherapy 59 intranasal insulin product 59 R sipuleucel T 59 Topical Interferon Alpha 2b 59 YONDELIS 59 Biologics License Applications 59 THALOMID 59 BYETTA ® 59 Anturol 59 cancer indications bafetinib 59 Vancocin R 59 unique alkylating agent 59 ocular formulation 59 Civacir 59 GRALISE 59 budesonide foam 59 Tezampanel 59 LEUKINE 59 Receives Tentative FDA 59 Frova R 59 equine osteoarthritis marketed 59 generation rotary VAD 59 CORLUX CORT # 59 BiTE R 59 CONBRIZA 59 serious cardiovascular thrombotic 59 sumatriptan DosePro 59 DexaSite 59 ZFP Therapeutics 59 indiplon capsules 59 TransVax TM 59 OTC BB PVCT 59 oxymorphone ER 59 Stavzor 59 Prostate Cancer Vaccine 59 cinacalcet HCl 59 novel trazodone formulation 59 ONTAK 59 OncoGel 59 NASDAQ PHRM 59 Cytogen marketed 59 class mGluR5 inhibitor 59 registrational trial 59 diarrhea nausea abdominal pain 59 Kristalose ® lactulose 59 CAPHOSOL R 59 Hedgehog Pathway Inhibitor 59 Oracea ® 59 APF# NDA 59 LUNESTA TM 59 Augment ™ 59 Orphan Therapeutics 59 levocetirizine 59 CDK cyclin dependent 59 lucinactant 59 Auxilium anticipates 59 TKM PLK1 59 Restanza TM 59 Marketing Authorization Application MAA 59 serine protease inhibitor CU# 59 generation PNP inhibitor 59 rxRNA 59 Grants Orphan Drug 59 Phase Ib IIa 59 Gabapentin GR 59 GTC NASDAQ GTCB 59 ZEGERID Powder 59 VALSTAR 59 brand ciclesonide HFA 59 NitroMist TM 59 Rhucin R 59 selective androgen receptor modulator 59 Ostarine ™ 59 Multiple Ascending Dose 59 Pivotal Phase II 59 ferumoxytol Injection 59 candidate MyVax 59 topical NSAID 59 Naglazyme R galsulfase 59 IND Investigational New 59 Exalgo 59 prokinetic agent 59 product platforms AZX# 59 REMOXY ® 59 DosePro TM 59 Tarsa Therapeutics 59 RIGScan ™ 59 RAPTIVA R 59 FDA APPROVES 59 Initiate Phase III 59 CINQUIL 59 postoperative ileus POI 59 mild vasodilator 59 Zolpidem Tartrate Tablets 59 Hematide TM 59 next generation URAT1 59 2 methoxyestradiol 59 Ketotransdel TM 59 ospemifene 59 PEGylated anti 59 number NCT# ClinicalTrials.gov 59 Presents Positive 59 Preotact 59 Phase 2b Trial 59 candidate brentuximab vedotin 59 Glybera 59 orally administered inhibitor 59 Phase IIb trials 59 Submits Investigational 59 Inc. NASDAQ ZLCS 59 cromolyn sodium 59 UltiMAb ® 59 azilsartan medoxomil 59 APTIMA HPV assay 59 Urocidin 59 Receives Milestone Payment 59 Zenpep 59 HepeX B TM 59 product Zingo TM 59 virus HCV protease inhibitor 59 Ranexa R 59 evaluating T DM1 59 RIGScan CR 59 topical anti infective 59 Kepivance 59 dacetuzumab SGN 59 TAFA# 59 hyaluronidase enzyme 58 Chemokine Therapeutics 58 REMOXY NDA 58 BCX# 58 FDA Orphan Drug 58 SUTENT ® 58 anthrax monoclonal antibody 58 bloodroot shark cartilage 58 Mepact 58 Severe hypersensitivity reactions 58 tizanidine hydrochloride short 58 LymphoStat B belimumab 58 Rhucin ® recombinant 58 Nexavar ® 58 R Saizen R 58 Selective Electrochemical Tumor Ablation 58 Ceragenin ™ 58 REVIVE Diabetes 58 markets Gelclair R 58 synthetic lipoglycopeptide antibiotic 58 docetaxel Taxotere R 58 mGluR5 negative 58 Tramiprosate ALZHEMED TM 58 ATPace TM 58 Nasdaq OSCI 58 Stedivaze 58 By JAMAAL ABDUL 58 pseudobulbar affect PBA 58 USP Tablets PEPCID 58 Ereska 58 Spiegelmer ® 58 Allovectin 7 R 58 testosterone buccal system 58 incyclinide 58 candidate ridaforolimus 58 visit www.genmab.com 58 Investigational Treatment 58 Bazedoxifene 58 TSX VENTURE GAP 58 Transcept Pharmaceuticals 58 ACTEMRA TM 58 FOLFOX6 chemotherapy regimen 58 Dalbavancin 58 Factor VIIa 58 NPSP# 58 ILUVIEN ® 58 Oral Spray 58 StemEx 58 HuCNS SC 58 hoFH 58 SILENOR ™ 58 alvespimycin 58 Fortical ® 58 Tekamlo 58 SNT MC# 58 Anidulafungin 58 POSIDUR TM 58 oral salmon calcitonin 58 alvimopan 58 INTERCEPT red 58 Neurodex 58 ALN VSP Phase 58 PGL# 58 see www.virexx.com 58 Immunomedics Announces 58 sublingual tablets 58 pregabalin Lyrica 58 synthetic peptide containing 58 compound INCB# 58 proprietary capillary aerosolization 58 Nasdaq PCYC 58 nephropathic cystinosis cystinosis 58 Synerx Pharma 58 molecular chaperone regulation 58 Dacogen injection 58 lorvotuzumab mertansine 58 please visit http:/www.sunesis.com 58 Generx ™ 58 candidate Zenvia 58 Nasdaq DVAX 58 Impax generic 58 Myocet 58 Xyntha 58 TRISENOX R 58 urocortin 2 58 Receives Positive Opinion 58 Uvidem 58 naronapride 58 TLK# 58 elotuzumab 58 Sudhir Agrawal D.Phil 58 Synvisc ONE 58 Targeted Chemotherapy 58 balsalazide disodium 58 BioMarin Genzyme LLC 58 MKC# MKC# PP 58 Opterone R 58 TOCOSOL Camptothecin 58 IND submission 58 PentaLyte R 58 Trizytek 58 palonosetron hydrochloride injection 58 VALSTAR R 58 EVIZON TM 58 submitted supplemental Biologics 58 dependent kinase inhibitor 58 Prestara TM 58 oral taxane 58 molecular therapeutics immunotherapies 58 FDA Approvable Letter 58 Bioaccelerate compounds under 58 NYSE Amex PTN 58 KALBITOR ® 58 Genasense R oblimersen 58 Talabostat 58 IAP inhibitor 58 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 58 Submits IND 58 Lovaza TM 58 evaluating tivozanib 58 Onalta ™ 58 adjuvant GIST 58 MethyPatch 58 Prednisporin TM 58 apricitabine ATC 58 ALN TTR 58 embroidered rosettes black 58 Nascobal R 58 FIRAZYR 58 Plenaxis R 58 Combination REOLYSIN R 58 MuGard TM 58 IoGen 58 Traci Arbios 58 OxyContin Chernoff 58 ALGRX 58 Initiates Clinical Trial 58 MEND CABG II 58 solanezumab 58 #D#C# 58 Adenosine Therapeutics 58 Phase IIb Clinical Trial 58 Pharmos pipeline 58 Retacrit 58 diarrhea predominant irritable 58 UPLYSO 58 Fibrillex TM 58 CDP# 58 Regeneron Pharma 58 BEMA TM Fentanyl 58 Fabry Disease 58 Phase #b/#a clinical 58 Horizant ™ 58 Pirespa 58 Levulan ® PDT 58 Soriatane 58 ZaBeCor 58 mesylate tablets 58 opioid bowel dysfunction 58 Psoriasis Drug 58 Therapeutic Competitors Companies 58 v Nastech 58 vaginally administered lidocaine 58 Celladon Corporation 58 R galsulfase 58 Phase 1b Clinical Trial 58 Intravenous Human 58 visit biotech.com 58 Schizophrenia Drug 58 vilazodone 58 Nasdaq DYAX 58 anaphylactic reactions bronchospasm 58 LHRH antagonist 58 SIX RO ROG 58 Actonel ® 58 arsenic trioxide injection 58 Ganciclovir 58 eprodisate KIACTA TM 58 NASDAQ INGN 58 Azedra TM Onalta TM 58 Trofex 58 Novolimus